Mismatched donor transplantation with post-transplantation cyclophosphamide for advanced cutaneous T-cell lymphoma: a single-center retrospective study

Leuk Lymphoma. 2022 Dec;63(12):2987-2991. doi: 10.1080/10428194.2022.2105330. Epub 2022 Aug 1.

Authors

Michael S Hughes¹, Cole H Sterling¹, Ravi Varadhan¹, Richard F Ambinder¹, Richard J Jones¹, Ronald J Sweren¹, Sima Rozati^{1

2}, Javier Bolaños-Meade¹, Leo Luznik¹, Philip H Imus¹, Syed Abbas Ali¹, Ivan M Borrello¹, Carol Ann Huff¹, Tania Jain¹, Alexander Ambinder¹, Amy E DeZern¹, Christian B Gocke¹, Douglas E Gladstone¹, Lode J Swinnen¹, Nina D Wagner-Johnston¹, Ephraim J Fuchs¹

Affiliations

¹ Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
² Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

PMID: 35915978
DOI: 10.1080/10428194.2022.2105330

No abstract available

MeSH terms

Cyclophosphamide / adverse effects
Graft vs Host Disease*
Hematopoietic Stem Cell Transplantation*
Humans
Lymphoma, T-Cell, Cutaneous* / drug therapy
Retrospective Studies
Transplantation Conditioning

Substances

Cyclophosphamide